Authors


Alon Kahana, MD, PhD

Latest:

Pearls for the treatment of patients with neurotrophic keratitis

Optimizing corneal neurotization outcomes with cryopreserved amniotic membrane.


Andrew D. Pucker, OD, PhD, FAAO

Latest:

The future of decentralized clinical trials in ophthalmology

Research can drive opportunities for patients with rare diseases


W. Lloyd Clark, MD

Latest:

ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTS

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.


Kenneth A. Beckman, MD, FACS

Latest:

The impact of cross-linking on corneal transplant rates

A Norwegian study demonstrates that transplant rates continue to drop over time


Grazia Pertile, MD

Latest:

Retinal detachments: managing retinal folds, role of anterior vitreous

Grazia Pertile, MD, discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.


Larissa Camejo, MD

Latest:

MicroPulse TLT offers proven versatility in the practice

Ophthalmologist offers pearls for use of technology in daily work.


Shigeru Kinoshita, MD, PhD

Latest:

Innovation and the clinician-scientist

A discussion with Shigeru Kinoshita, MD, PhD; and Edward J. Holland, MD.


Scott D. Walter, MD, MSc, FASRS

Latest:

Final Thoughts on Case Presentations and Advanced Therapies

Retinal specialists conclude their discussion with key highlights from each patient case of retinal vascular disease and pearls the audience can apply in their practice.


Panayiota Founti, PhD, FEBO

Latest:

Patient glaucoma management focuses on pivotal studies

Randomly assigned controlled trials key in increasing understanding of disease.


Eva Kim, MD

Latest:

Pearls for incorporating phakic IOLs into your practice

Surgeons can refine their workflow, partner with an optometrist.


Paul Badawi

Latest:

What’s Your WhEYE? A conversation with Paul Badawi, CEO of Sight Sciences

Paul Badawi, co-founder and CEO of Sight Sciences, sits down with host Neda Shamie, MD, to discuss his journey into the field of eye care, what motivates him, the transformative approach to glaucoma patient care, and the spark that led him and his ophthalmologist brother, David Badawi, MD, to start the company together.


Joel S. Schuman, MD

Latest:

Should we always trust the OCT?

There are times when physicians should be critical of scans.


Farhad Hafezi, MD, PhD, FARVO

Latest:

Transforming the eye with a new standard for corneal cross-linking

The new standard: Stabilizing keratoconus and improving vision.


Alain M. Bron, MD

Latest:

MIGS helping to personalize glaucoma surgery options

Although minimally invasive procedure gives hope, additional research is required.


Lee MacMorris

Latest:

Evolution of optical coherence tomography of the human eye

Adolf Fercher's 2D image of fundus paved way for today’s imaging technique.


Thomas Aaberg Jr, MD

Latest:

A roadmap to preserving the prime years of patients diagnosed with MacTel

According to Thomas Aaberg, MR, the novel therapy is geared to treat rare, debilitating eye disease.


Sapna Gangaputra, MD, MPH

Latest:

Diagnostic Maze: Navigating the complexity of isolated optic disc edema in syphilitic uveitis

With cases of syphilitic uveitis on the rise, recognizing its varied presentations—including optic disc edema, which may appear without other significant eye inflammation—is increasingly important for timely diagnosis and treatment.


Winston Posvar, OD, MS

Latest:

The future of decentralized clinical trials in ophthalmology

Research can drive opportunities for patients with rare diseases


Randy McNamara

Latest:

Fulfilling expectations: A super highway to workability

A powerful conversation about expectations can open communication and trust.


Christine Larsen, MD

Latest:

Adherence and tolerability are key in treatment of hypertension and glaucoma

Priorities can ensure optimal outcomes for patients diagnosed with diseases.


Daniel F Kiernan, MD, FACS

Latest:

Impressions and Takeaways From Patient Case #2

Daniel F Kiernan, MD, FACS, discusses the use of anti-inflammatory treatment when experiencing sub-optimal response with anti-VEGF therapy in DME.


Sonya Besagar, MD

Latest:

Diagnostic Maze: Navigating the complexity of isolated optic disc edema in syphilitic uveitis

With cases of syphilitic uveitis on the rise, recognizing its varied presentations—including optic disc edema, which may appear without other significant eye inflammation—is increasingly important for timely diagnosis and treatment.


Sharon Fekrat, MD, FASRS

Latest:

Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwide

Answers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.


Jason Smith, DNP, CRNA

Latest:

Study finds sublingual troche, IV sedation are equivalent for cataract surgery

The method by which sedation is applied to keep patients relaxed and comfortable throughout cataract surgery can be tailored similar to that of anesthesia — surgical anesthesia is not a one size fits all endeavor.


Victor A. Augustin, MD

Latest:

Artificial DMEK could help tackle endothelial donor tissue shortage

New acrylic implant provides option for patients with endothelial dysfunction.


Marc R. Bloomenstein, OD, FAAO

Latest:

Topical presbyopic correction: a postoperative problem solver

Presbyopia-correcting drops represent a whole new product category—one with a lot of upsides for clinicians who want to help their patients see well at all distances.


Vasant Raman, MS, FRCS

Latest:

Should nonclinicians inject dexamethasone implants?

Studies on nurse-led services find a low level of complications among patients.


Michael Greenwood, MD

Latest:

Advantages of incorporating ECP into the surgeon’s armamentarium

Short learning curve, significant clinical advantages make this a comfortable addition.


Saif Alryalat, MD

Latest:

What ophthalmologists need to know about neuromyelitis optica spectrum disorder

Early diagnosis of NMOSD is key to preventing disability, improving survival.


Phillip H. Phan, PhD

Latest:

Clearing hurdles to large scale telemedicine adoption

During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye

© 2024 MJH Life Sciences

All rights reserved.